Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4/VPS15) is a large regulatory subunit of the Class III PI3K complex. It acts as a molecular scaffold that coordinates the localization and activation of VPS34 (the catalytic lipid kinase) to produce phosphatidylinositol 3-phosphate (PI3P) on cellular membranes. PI3P generation is essential for autophagy initiation, endosome maturation, and vesicular trafficking. Unique among kinases, its pseudokinase domain binds GTP and is regulated through N-myristoylation, controlling complex assembly and activity. Dysfunction or genetic mutations in PIK3R4/VPS15 are implicated in neurodegenerative conditions, and dysregulation of autophagy pathways in cancer and other diseases highlights its importance as a therapeutic target.
Drugs targeting VPS34-PIK3R4 complexes usually act by inhibiting kinase activity (autophagy inhibition), stabilizing complex conformations, or modulating association with membranes to control PI3P production. GTP-binding and myristoylation of the pseudokinase domain are critical regulatory mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide 3-kinase regulatory subunit 4 (PIK3R4).